Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
India’s anti-obesity drug market is on the brink of a major transformation, with prices of popular weight-loss medications…
Table 2.0: Restaurants absorb ‘Ozempic effect’ for weight-loss drug consumers
New Delhi:Dozens of Indian restaurants and cafe chains are fast-tracking Size O menus — the O standing for…
How GLP-1 drugs affect the body beyond weight loss and glucose control
Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks,…
Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasible
HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
Users prioritize weight loss despite side effects
An examination of user reviews finds that people continue off-label Ozempic when it delivers results, even if side…
New drug CagriSema leads to 14% weight loss in trial
Share on PinterestNew combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to…
Health Canada warns of fake semaglutide drugs, cites ‘product safety’ risks – National
Health Canada is warning Canadians of the dangers of buying “fake or unauthorized products” meant to replicate popular…
What is ‘natural Ozempic’ – and how good is the science?
A food-oil supplement called Elcella can work like a weight-loss jab, it has been claimed – but experts say…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
Eli Lilly Drug Retatrutide Clinical Trial Results
3 min readEli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it…
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
Efficacy of GLP-1 receptor agonists on obesity and metabolic profile in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology
Elangovan A, Shah R, Ali SM, Katz J, Cooper GS. High burden of obesity and low rates of…